SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 9.93 |
| Enterprise Value ($M) | 31.66 |
| Book Value ($M) | -6.00 |
| Book Value / Share | -0.71 |
| Price / Book | -1.66 |
| NCAV ($M) | -18.37 |
| NCAV / Share | -2.16 |
| Price / NCAV | -0.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.08 |
| Return on Assets (ROA) | -0.70 |
| Return on Equity (ROE) | -4.59 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.85 |
| Current Ratio | 2.85 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 28.89 |
| Assets | 41.27 |
| Liabilities | 47.26 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 10.91 |
| Operating Income | -44.54 |
| Net Income | -43.39 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -39.56 |
| Cash from Investing | 29.44 |
| Cash from Financing | 3.44 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Bleichroeder LP | 9.90 | ||
| 13G/A | Maverick Capital Ltd | 8.00 | 17.02 | |
| 13G/A | Satterfield Thomas A Jr | 9.10 | 14.48 | |
| 13G/A | Kingdon Capital Management, L.l.c. | 1.50 | -73.97 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 110,515 | 278,672 | 39.66 | |
| 24,127 | 79,573 | 30.32 | |
| 69,049 | 144,546 | 47.77 | |
| 40,519 | 119,100 | 34.02 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CPRX – Catalyst Pharmaceuticals, Inc. | CRBP – Corbus Pharmaceuticals Holdings, Inc. |
| CRDF – Cardiff Oncology, Inc. | CRVO – CervoMed Inc. |
| CSBR – Champions Oncology, Inc. |